approved EB-2 (NIW)

Senior Scientist

Cancer Biology · Vietnam · 2022-04-16

Processing Time
76 days
Decision Date
2022-04-16
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to utilize her expertise in advanced molecular, chromosomal, and DNA tools to investigate the mechanisms of chromosomal rearrangement that drive cancer. Her work focuses on identifying novel therapies for aggressive forms of pediatric cancer, such as malignant rhabdoid tumors, and developing castrate-resistant prostate cancer lines to study molecular mechanisms of resistance.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor provides the basis for more effective cancer therapeutics for childhood and prostate cancers, impacting millions of Americans.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 7 years of experience, a record of peer-reviewed publications, and has secured funding from prestigious institutions like the NIH and DoD.

3 Balance of Interests Met

The petitioner's contributions to pediatric cancer research and genomic study frameworks make it beneficial to waive the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's 7 years of research experience, resulting in 4 peer-reviewed journal articles and 34 citations. Her work was supported by funding from major government agencies including the NIH, NCI, and the Department of Defense, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Government Alignment

Similar Cases

Physician

Healthcare · Singapore

WeGreened EB-2 (NIW) rfe approved
New York 317 days 2022-10-12
The petitioner proposes to continue investigating genetic factors and underlying mechanisms that modulate patient health outcomes to devise systems-level methodologies for the diagnosis, treatment, and management of internal diseases. Her work specifically focuses on chromosomal stability and identifying centromeric locations of instability to develop targeted cancer therapies.

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
Texas 6 days 2023-05-01
The petitioner proposes to define molecular mechanisms mediating chromatin regulation to discover novel nodes for the development of drugs that treat rhabdomyosarcomas and other cancers. This work focuses on understanding muscle cell functions as they relate to cancer to develop more effective and less invasive treatment approaches.

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
195 days 2022-05-06
The petitioner proposes to continue developing genomic screening platforms and gene therapy-based approaches to facilitate the design of novel treatment modalities for cancer. This work focuses on identifying genetic factors that contribute to cancer development and progression using state-of-the-art molecular methods.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-16.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 76 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist